Compugen Ltd. (CGEN) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Compugen Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.196 Thank you for joining us today. Welcome to CompuGent's fourth quarter and full year 2025 00:00:05.196 -- 00:00:10.200 Revolve Council's call. At this time, all participants are in 00:00:10.200 -- 00:00:15.625 listen-only mode. An audio webcast of this call is available in the investor 00:00:15.625 -- 00:00:18.826 section of CompuGent's website, 00:00:18.988 -- 00:00:20.988 www.cgen.com. 00:00:21.250 -- 00:00:24.853 As a reminder, today's call is being recorded. 00:00:24.853 -- 00:00:29.867 With us from the CompuGent team are Dr. Erana Fil, President and CEO, and 00:00:29.867 -- 00:00:33.393 David Silberman, Chief Financial Officer. Dr. 00:00:33.393 -- 00:00:38.401 Michelle Mahler, Chief Medical Officer, will join for the Q&A. 00:00:38.401 -- 00:00:43.168 Before we begin, we would like to remind you that during this call, the company may make 00:00:43.168 -- 00:00:48.376 projections or forward-looking statements regarding future events, business 00:00:48.376 -- 00:00:53.484 outlook, development efforts, and their potential outcome, the company's 00:00:53.484 -- 00:00:59.167 discovery platform, anticipated progress and plans, results and timelines 00:00:59.167 -- 00:01:04.454 for our program, including disclosure of clinical data, financial 00:01:04.454 -- 00:01:10.362 and accounting-related matters, as well as statements regarding our cash position 00:01:10.362 -- 00:01:12.384 and cash runways. 00:01:12.384 -- 00:01:17.551 We wish to caution you that such statements reflect only the company's current 00:01:17.551 -- 00:01:23.158 beliefs, expectations, and assumptions, but actual results, performance, 00:01:23.158 -- 00:01:28.000 or achievements of the company may differ materially. 00:01:28.000 -- 00:01:33.625 These statements are s...